I agree with what you've written & thank you for doing that.
Sometimes there's nothing that can (currently) be done & the Doctors job is just to say that -- not come off with some misleading crap.
Oh & Doctors should point patients to this type of forum - I was tempted to say this forum may not...
If rituximab kills all antibody producing B-cells then, if the "'messy' antibodies" are solely produced by B-cells, rituximab should work? Suppose the another option is plasma cells i.e. producing antibodies?
Is the regulatory mechanism (for checking antibodies) is common to both B-cells &...
Very interesting thanks - I wonder whether GWAS [common variant genetic study - DecodeME], or indeed a rare variant genetic study*, would provide an independent route to test this e.g. certain genes increasing severity --- likelihood of this outcome & if so then what genes?
*NIH - a rare...
Akiko Iwasaki is at Yale & Yale researchers have been working on a technique to identify autoantibodies*. However, I do still wonder if this is a reliable technique - you'd like to think that the proposed +ve result [autoantibodies] has been tested using a number of techniques...
Surely if you go a Doctor & they cannot explain your symptoms then one explanation is -- well the Doctor is poor? If the Doctor asks colleagues maybe the % decreases --- apart from identifying gaps in medical knowledge I don't think this tells us much.
Yes, I can imagine Paul Garner might...
I recall that @Jonathan Edwards wrote that the MRC group (he was part of) proposed funding a GWAS [common variant] genetic study [DecodeME] - the only other promising area was a sleep study - actimetry?
I'm also interested in sleep since my family member has poor sleep quality; therefore I...
The only time I attended Nath & Vicky Whittemore were both there --- mingling after their talks.
Vicky highlighted that:
a rare disease she was responsible for had just had a breakthrough - causative gene identified and thus drug development could begin; and
the underlying cause of ME/CFS...
I wonder if Nath is/was hen pecked i.e. by Walitt? Either way, Nath should have held the line that the evidence wasn't there to support the claims made in the paper!
I rather like your (SNT Gatchaman) post (from memory) i.e. "Doctors need to demand diagnostic tests ---". I'd tweak that slightly i.e. "we need to co-operate with Doctors and vice versa --- to deliver diagnostic tests (biomarkers) ---". @Jonathan Edwards is a brilliant example of what we...
I recall Angela Vincent saying that 10+ years ago.
Yes, I'm a bit worried the Decode ME data may be too heterogeneous i.e. a number of diseases (different pathologies) get the label "ME/CFS". In dementia the first gene turned up relatively early [apolipoprotein] but the subsequent (2?) genes...
I think I noticed that Jonathan commented that there had been serendipitous cases i.e. where rituximab had been given to people with autoimmune arthritis and the improvement in their arthritis noted - indicating autoimmune antibodies. So there are "natural" experiments going on - does that...
Thank you - interesting that "Ian Lipkin applied for a NIH grant for a small GWAS" - hopefully the approach means that the data could be combined with DecodeME.
Interesting re Jarred Younger/Kiz Worthy i.e. rare variant study -- yea sample size (& selection criteria) would be interesting.
Thanks Simon & don't feel obliged to reply to this.
Interesting --- don't suppose NIH would fund a whole genome sequence study i.e. based on the DecodeME samples!
I've noticed that using families with 2 or more members affected, and at least 1 severe, has been suggested - not clear what the...
Maybe first step would be to see what DecodeME turns up [results due to be published by middle of 2025?] -- if that supports this theory then the barriers (re biopsy) become a bit easier to overcome + bodies like MRC (UK) & NIH (US) may be more supportive/proactive.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.